ArticleJTO clinical and research reports2022

Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring

Shun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.